At Ever Better Labs, White Papers are not marketing materials. They are working documents—created to clarify what is known, what remains uncertain, and what outcomes we are attempting to measure through structured research and observation. White Papers Peptide Therapeutics for Future Modulation of Neurological Diseases and Disorders Semax and its potential future therapeutic uses for ADHD and related neurological disorders GLP-1 Masterclass:Mechanisms, Pharmacokinetics, Precautions and What to Expect.